Acadian Asset Management »

Avalo Therapeutics Ord shares owned by Acadian Asset Management

Quarter-by-quarter ownership of Avalo Therapeutics Ord (AVTX) shares owned by Acadian Asset Management from 13F filings

Historical chart of Acadian Asset Management investment in Avalo Therapeutics Ord

Tip: Access up to 7 years of quarterly data

All positions including Avalo Therapeutics Ord held by Acadian Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avalo Therapeutics Ord by Acadian Asset Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $26k 1.5k 17.68

More positions owned by Acadian Asset Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Amazon (AMZN)
Bk Nova Cad (BNS)
JPMorgan Chase & Co. (JPM)
Toronto Dominion Bk Ont Com New (TD)
Deutsche Bank A G Namen Akt (DB)
Ubs Group SHS (UBS)
Broadcom Ord Shs (AVGO)
Booking Holdings (BKNG)
Citigroup Com New (C)
Telefonaktiebolaget Lm Erics Adr B Sek 10 (ERIC)

View all positions for Acadian Asset Management

Top funds holding Avalo Therapeutics Ord

BVF
OrbiMed Advisors
Nantahala Capital Management
Point72 Asset Management
Affinity Asset Advisors
Caligan Partners
Balyasny Asset Management
Vanguard Group
Silverarc Capital Management
RA Capital Management
Marshall Wace
Citadel Advisors
TCG Crossover Management
Commodore Capital
UBS Group

View all funds holding Avalo Therapeutics Ord